Vivoryon Therapeutics N.V. to Report Full Year 2024 Financial Results and Operational Progress on April 29, 2025 Halle (Saale) /…
For the seventh consecutive year, company discloses detailed assessment of sustainability metrics and targets SPARTANBURG, S.C., April 16, 2025 /PRNewswire/ --…
April 16, 2025 08:00 ET | Source: Akari Therapeutics Plc Advancing development of next-generation precision Antibody Drug Conjugates (ADCs) to…
With Revenue, Gross Margin, Order Volume, and Cash Flow All Achieving Simultaneous Growth in 2024 SHANGHAI, April 16, 2025 /PRNewswire/…
NOIDA, India, April 15, 2025 /PRNewswire/ -- ACT21 Software, a pioneering force in financial technology, has received the prestigious Best…
KUALA LUMPUR, Malaysia, April 15, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) (“BioNexus” or the “Company”), a…
Revenue and EBIT increased again in 2024, despite a volatile environmentNumber of core employees grew furtherDEKRA is very well positioned in…
MILPITAS, Calif., April 14, 2025 /PRNewswire/ -- Electronic System Design (ESD) industry revenue increased 11% to $4,927.3 million in the…
Châtillon, France, April 11, 2025 DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document…
SCOTTSDALE, Ariz., April 11, 2025 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American:…
